What is the treatment for pinguecula?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Pinguecula

For symptomatic pinguecula with inflammation, topical indomethacin 0.1% solution is the preferred first-line treatment, administered 4-6 times daily for 2 weeks, as it provides equivalent efficacy to corticosteroids without the risk of rebound inflammation upon discontinuation. 1, 2

Conservative Management Approach

Asymptomatic Pinguecula

  • No treatment is necessary for asymptomatic pinguecula, as these are benign lesions that do not affect vision 3
  • Observation alone is appropriate when patients have no complaints of irritation, redness, or cosmetic concerns 3

Symptomatic Pinguecula - First-Line Therapy

Topical NSAIDs are the treatment of choice:

  • Indomethacin 0.1% solution should be administered 6 times daily for 3 days, then reduced to 4 times daily for 11 additional days 1
  • This regimen significantly reduces both objective signs (conjunctival congestion, redness, edema) and subjective symptoms (photophobia, pain, foreign body sensation, tearing) within 3 days 1
  • Improvement continues progressively through day 14 of treatment 1
  • Patients should expect mild stinging lasting less than 1 minute after drop administration 1

Alternative Anti-Inflammatory Options

If indomethacin is unavailable or not tolerated:

  • Dexamethasone phosphate 0.1% solution can be used with the same dosing schedule (6 times daily for 3 days, then 4 times daily for 11 days) 2
  • However, corticosteroids carry a significant disadvantage: rebound inflammation occurs after discontinuation, with recurrence of signs being significantly greater at 2-4 weeks post-treatment compared to indomethacin 2
  • Preservative-free formulations should be prioritized when using topical corticosteroids to minimize additional conjunctival irritation 4

Adjunctive Symptomatic Relief

  • Preservative-free artificial tears can be used for minor irritation and dryness symptoms 3
  • These provide lubrication but do not address the underlying inflammation 3

Novel Experimental Therapies

  • Topical dipyridamole in normal saline solution has shown promise in a single case report, with regression of tissue and resolution of symptoms over 12 months 5
  • However, this remains investigational and requires further study before routine clinical use 5

Important Clinical Pitfalls

Avoid these common errors:

  • Do not confuse pinguecula with pterygium - pinguecula does not cross the limbus onto the cornea, while pterygium does 6, 3
  • Do not rush to surgery - pinguecula rarely requires surgical intervention, unlike pterygium which may affect the visual axis 3
  • Do not use corticosteroids as first-line therapy - while effective, they cause more rebound inflammation than NSAIDs after discontinuation 2
  • Do not ignore persistent symptoms - if inflammation does not respond to 2 weeks of topical NSAIDs, reassess the diagnosis to exclude other conditions 1

When to Refer

  • Ophthalmology referral is appropriate if symptoms persist despite appropriate medical therapy for 2-4 weeks 1
  • Surgical excision is rarely indicated for pinguecula and should only be considered for severe cosmetic concerns or persistent symptoms refractory to all medical management 3

References

Research

Pingueculae and pterygia.

Survey of ophthalmology, 1988

Guideline

Treatment and Management of Pinguecula

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update on overview of pterygium and its surgical management.

Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.